Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

AVIR vs TTRX: stock comparison and AI forecast

Atea Pharmaceuticals, Inc. (AVIR) and Turn Therapeutics Inc. (TTRX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

AVIR Atea Pharmaceuticals, Inc.

Price
$4.17 -25.5% · 6M
Market Cap
$334M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

TTRX Turn Therapeutics Inc.

Market Cap
$311M
P/E Ratio
–
Size
small-cap
AI Forecast
NO CURRENT FORECAST
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

AVIR · TTRX

Key facts

  • AVIR and TTRX have similar market capitalizations ($334M and $311M).
  • TTRX carries 23.69 times debt per unit of equity, against 0.14 times for AVIR.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricAVIRTTRX
Market Cap$334M$311M
P/B Ratio1.64x452.31x
EPS$-1.91$-0.32
Book Value/Share$2.55$0.02

Profitability & Margins

MetricAVIRTTRX
ROE-81.0%-1458.0%
ROA-71.2%-59.0%
ROIC-89.9%-106.5%
Tax Rate3.8%–

Financial Health

MetricAVIRTTRX
Current Ratio8.13x1.19x
D/E Ratio0.14x23.69x
Financial Leverage1.14x24.69x
Interest Coverage–-6.9x
Working Capital$201M$2M

Cash Flow

MetricAVIRTTRX
Operating Cash Flow-$152M-$5M

Income Statement

MetricAVIRTTRX
Operating Income-$184M-$9M
Net Income-$165M-$10M
R&D Expense$155M$850K

Dividend & Shareholder Information

MetricAVIRTTRX
Shares Outstanding80M30M
FAQ

AVIR vs TTRX: stock comparison and AI forecast

Which is bigger, AVIR or TTRX?

AVIR and TTRX have similar market capitalizations ($334M and $311M).

Which one does Intratio's AI model rank higher, AVIR or TTRX?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.